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PSMD10Gankyrin, a proteasome assembly chaperone, is a widely known oncoprotein which aspects many hall mark proper-
ties of cancer. However, except proteasome assembly chaperon function its role in normal cell function remains 
unknown. To address this issue, we induced PSMD10Gankyrin overexpression in HEK293 cells and the resultant large- 
scale changes in gene expression profile were analyzed. We constituted networks from microarray data of these differ-
entially expressed genes and carried out extensive topological analyses. The overrecurring yet consistent theme that 
appeared throughout analysis using varied network metrics is that all genes and interactions identified as important 
would be involved in neurogenesis and neuronal development. Intrigued we tested the possibility that PSMD10Gankyrin 
may be strongly associated with cell fate decisions that commit neural stem cells to differentiate into neurons. 
Overexpression of PSMD10Gankyrin in human neuronal progenitor cells facilitated neuronal differentiation via β-catenin 
Ngn1 pathway. Here for the first time we provide preliminary and yet compelling experimental evidence for the involve-
ment of a potential oncoprotein – PSMD10Gankyrin, in neuronal differentiation.
Keywords: Gankyrin, Human neuronal progenitor cells, Microarray, Neurogenesis, Proteasome, PSMD10
Introduction 
  PSMD10, also called Gankyrin (PSMD10Gankyrin), is a 
well-established proteasome assembly chaperone and an 
oncoprotein. Initially identified as p28 component (Nas6/ 
PSMD10) of 19S regulatory subunit of the 26S proteasome 
(1), PSMD10 later gained importance for its tumorigenic 
potential in many cancers by regulating multiple signaling 
pathways (2, 3). From a structural perspective PSMD10Gankyrin 
belongs to ankyrin repeat family proteins, well-known for 
their role as mediators of protein-protein interactions that 
regulate numerous physiological processes (4, 5). Most im-
portantly PSMD10Gankyrin acts as a dual-negative regulator 
of both pRb and P53 tumor suppressor pathways, by mod-
ulating their ubiquitin mediated proteasomal degradation 
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via specific protein-protein interactions (6, 7). 
  The well-established association of PSMD10Gankyrin with 
various cancers overshadows its role in normal cells. As 
a 19S assembly chaperone, PSMD10Gankyrin is central to the 
building of the base complex and aids in its association 
with the 20S core particles (8). Ability of PSMD10Gankyrin 
to retain NF-κB in the cytoplasm (9) and regulate its 
transcriptional activity at the basal level, may be a critical 
checkpoint in normal cells. PSMD10Gankyrin enhances the 
transcriptional activity of β-catenin/TCF3 complex (10) 
that drives Wnt signaling, a major player in cellular dif-
ferentiation process. Our recent study reported number of 
proteins that interact with endogenous PSMD10Gankyrin in 
mammalian cells (11). PSMD10Gankyrin interactions with 
Hsp70 and Hsp90 chaperones that help in the turnover 
of proteins may be critical during heat shock response or 
ER stress. These limited and yet important interactions 
bring forth the role of PSMD10Gankyrin in cellular homeo-
stasis. 
  To obtain deeper insights on the biological role of 
PSMD10Gankyrin, we generated microarray gene expression 
profiles by overexpressing PSMD10Gankyrin in HEK293 cells 
used as a model system in our previous studies. The data 
were analyzed using a combination of topological inves-
tigation of networks, gene-set enrichment and pathway 
analysis. This strategy led us to a remarkable prediction, 
namely – the potential involvement of PSMD10Gankyrin in 
the biogenesis of neurons and neuronal functions. Al-
though such networks can have wider biological implicati-
ons, this analysis focused our attention on a human neuro-
nal progenitor cells (hNPCs) model system for differen-
tiation. Here we provide preliminary and yet compelling 
evidence for the role of PSMD10Gankyrin in neurogenesis. 
We show that both the mRNA and protein levels of 
PSMD10Gankyrin increase in differentiated cells compared 
to the hNPCs. This increase in PSMD10Gankyrin parallel the 
time-dependent increase in β-tubulin, a marker of the 
differentiated neurons. Overexpression of PSMD10Gankyrin 
in hNPCs cell line induces the expression of Ngn1 and 
alters the ratio of neurons to astrocytes favoring the proc-
ess of neurogenesis. 
Materials and Methods
Plasmids and cloning
  PSMD10Gankyrin gene was cloned in pCMV10-3XFlag 
vector to generate stable cell-line in HEK293 cells. 
PSMD10Gankyrin with N-term 3XFlag tag was cloned into 
AgeI and EcoRI sites of pTRIPZ vector under minimal 
CMV promotor with a KOZAC sequence (CGCCACC-
ATG) replacing the RFP gene from the vector. PAX2 and 
pMD2G packaging vectors were used for virus production.
Cell culture, generation of stable cells and transduction
  HEK293 and HEK293-FT cells were grown in DMEM 
with 10%FBS supplement, 5% CO2 at 37℃. Stable cells 
for PSMD10Gankyrin overexpression were generated by 
transfecting HEK293 cells with pCMV10-3XFlag- 
PSMD10Gankyrin construct and selected with (800 μg/mL) 
G418 (Sigma). For PSMD10Gankyrin silencing HEK293 cells 
were transfected with siRNA using Lipofectamine 
RNAiMax (Invitrogen) and incubated for 48 hrs. Human 
Neural progenitor cells (ReNcell VM, purchased from 
Millipore) were grown on laminin (10 μg/mL: Sigma) coat-
ed plates or cover slips in Neural Stem Cells maintenance 
media (Millipore) supplemented with EGF and FGF (20 
ng/mL each: Sigma). hNPCs grow rapidly as a monolayer 
on laminin with a doubling time of 20∼30 hours (Supple-
mentary Fig. S1). For differentiation studies cells were 
differentiated into astrocytes, oligodendrocytes and neu-
rons (Supplementary Fig. S1B, S1C, S1D, S1E) in 10∼14 
days of incubation period by withdrawing EGF and FGF 
as per the manufacturers protocol (Millipore). hNPCs were 
transduced with high titer lentiviral particles along with 
polybrene for 3XFlag-PSMD10Gankyrin overexpression 
(More details in Supplementary methods).
Microarray and data analysis
  RNA was isolated from ∼1×106 HEK293 stable clone 
cells overexpressing PSMD10Gankyrin and the Vector Con-
trol HEK293 clone by the TRiZol (Invitrogen) method fol-
lowing manufacturers protocol. The isolated RNA was 
outsourced to Genotypic Technology (Bangalore, India). 
After their quality control report, cDNA was prepared in-
house and was later analyzed by microarray using the the 
Agilent platform. The data were analyzed using Agilent 
expression reference guide. Network reconstruction and 
extensive topological analysis of networks were carried out 
using various bioinformatics tools (More details in Sup-
plementary methods).
Semi quantitative and real-time PCR
  mRNA from PSMD10Gankyrin stable cells, control 
HEK293 cells, hNPCs (UD) and Differentiated (DF) cells 
were isolated by TRiZol (Invitrogen) reagent and cDNA 
were prepared using Reverse transcriptase (Invitrogen) 
PCR. Semi-Q PCR and Real time PCR were carried out 
for target genes using different PCR primers (Supplemen-
tary information).
Indrajit Sahu, et al: Role of PSMD10Gankyrin in Nueronal Differentiation  3
Western blot and antibodies
  PSMD10Gankyrin stable cells, control HEK293 cells, hNPCs 
(UD) and Differentiated (DF) cell lysates were prepared 
with NP-40 lysis buffer (50 mM Tris pH7.4, 150 mM 
NaCl, 1% NP-40, 1 mM DTT and 1× protease inhibitors) 
and immunoblotting was performed with different anti-
bodies (Suplementary materials). 
Luciferase assay
  PSMD10Gankyrin stable cells, control HEK293 cells were 
transfected with TopFlash and Renilla constructs at a ra-
tio of 10：1 respectively using Fugene-HD (Promega). 
Cells were incubated for 48 hrs post transfection followed 
by cell lysis using 1× luciferase passive lysis buffer (Dual 
luciferase reporter assay, Promega). Firefly and renilla lu-
ciferase activity were measured using a plate reader (Cyta-
tion 5).
Immunofluoroscence
  The UD or DF cells were fixed with 4% PFA for 20 
min at RT, permeabilized with 0.3% Triton-X100 contain-
ing 5% BSA in 1× PBS for 2 h at RT. Primary antibodies 
and secondary antibodies were duluted with the blocking 
solution and incubated for 1 h at RT or ON at 4℃. For 
nuclear staining cells were treated with 1 μg/mL of DAPI 
for 60 sec. Images were taken by Laser confocal micro-
scope (Zeiss LSM meta 510).
Densitometric and statistical analysis
  Densitometric quantification of scanned western blot 
images was performed using Mac BioPhotonics ImageJ. 
Statistical analysis was performed using Graph Pad Prism 
5. To evaluate the significance of values obtained, un-
paired Student’s t test was performed. p＜0.05 and p＞
0.05 are considered as significant and non-significant data 
respectively. ***represents p-value<0.001 and **repre-
sents p-value＜0.01.
Results and Discussion
Network and pathway analysis of microarray genes 
predicted probable role of PSMD10Gankyrin in neuronal 
differentiation
  In order to characterize the impact of PSMD10Gankyrin 
on global gene expression, we carried out a microarray 
analysis of the total RNA isolated from PSMD10Gankyrin 
overexpressing HEK293 stable-cells (Fig. 1A) and identi-
fied the differentially expressed genes compared to vector 
control cells. Following an extensive and stringent net-
work reconstruction (Supplementary methods) we identi-
fied 249 genes, 292 edges and 7 hub genes, or the genes 
whose degree is much higher than the average degree of 
our network, G (Fig. 1B). The leading genes in G with 
respective degree mentioned in parenthesis, are: ptpn3 
(92), artn (65), neurog1 (53), nefm (30), cebpa (19), galc 
(9) and tnxb (8). Genes with the highest node betweenness 
centrality in G are ptpn3 (0.1326), artn (0.1221), nefm 
(0.09856), il1b (0.0873), neurog1 (0.0794), mapk1 
(0.05973), lif (0.0212), akt1 (0.0199) etc. Genes with the 
highest node closeness centrality in G are: artn (0.2326), 
il1b (0.2058), bdnf (0.2058), neurog1 (0.1898), ngfb 
(0.1690). We next turned our attention to edge-based met-
rics in networks. Edges with the highest values of edge 
betweenness are (nefm - il1b), (il1b - artn), (mapk1 - nefm), 
(ptpn3 - mapk1), (lif - artn), (neurog1 - lif) etc. Edges with 
the highest values of edge proximity (12) consistently have 
artn, neurog1 and nefm at one of their ends. To extract 
the biological information from these edges, we used 
Uniprot to annotate the nodes. This annotation led us to 
the following biological intuition: the genes and inter-
actions identified as important by various network metrics 
seem to be involved in neuronal differentiation (Fig. 1B) 
and therefore we speculated PSMD10Gankyrin could regulate 
cell fate decisions. 
  In an independent approach, the cohort of upregulated 
genes (1.2 log 2 fold changes and above) were analyzed 
using various web-based bioinformatics tools: GSEA and 
DAVID functional annotation (13-15). KEGG and Reac-
tome biological pathway analysis sought out statistically 
significant top hits (with high p-value & FDR q-value) in-
cluded developmental process, compartmentalization, sig-
naling and functions involving the neurons (Fig. 1C, 1D, 
Supplementary Table S1, S2). Although less significant by 
FDR measures but with a p-value of 0.057, one of the hits 
annotated within DAVID functional analysis was neuro-
genesis (Supplementary Table S3, S4). Representative 
genes with the expression values (fold change≥3) and 
having involvement in neuronal biology are included in 
Fig. 1E. By Real-time PCR we confirmed mRNA levels 
of Ngn1 (Neurogenin1), Nrg1 (Neuregulin1) along with 
PSMD10Gankyrin are higher in PSMD10Gankyrin clones than 
that of vector control cells (Fig. 1F). 
PSMD10Gankyrin levels increase during differentiation of 
hNPCs 
  With the above network analyses in place, we infer on 
the potential role of PSMD10Gankyrin and tested the role of 
PSMD10 in the differentiation of human neural progeni-
tor cells (hNPCs). First, we checked the differentiating po-
tential of the hNPCs in a monolayer culture (Fig. 2A∼C 
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Fig. 1. Microarray and Network analysis of HEK293 cells upon PSMD10Gankyrin overexpression. (A) Workflow for Microarray and bio-
informatics analysis upon PSMD10Gankyrin overexpression in HEK293 cells. The anti-PSMD10Gankyrin WB image shows the expression of 
Flag-PSMD10Gankyrin and endogenous PSMD10Gankyrin from the lysates of control and overexpressed PSMD10Gankyrin HEK293 cells. (B) Network 
depicts the role of the top five genes possessing the highest node betweenness centrality (yellow diamond), for overexpressed PSMD10Gankyrin
in HEK293 cells. Only interactions of the "other" genes (purple diamond) with these five most "between" genes is shown. Mutual interactions 
among these "other" genes is excluded. Interestingly, this network shows few "other" genes interacting simultaneously with two "between" 
genes. Further, none of the "other" genes interacts simultaneously with three of the most "between" genes. The insert table shows the 
value of degree and Node betweenness centrality for the top five genes. (C) The GSEA set of genes were analyzed in KEGG pathway 
analysis. The bubble chart depicting the topmost pathways (with highest p-values and FDR q-values) altered upon overexpressed 
PSMD10Gankyrin. Each bubble represents a pathway with gene number involved and had appeared in the GSEA gene set. In the table the 
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Fig. 1. (Continued) above pathways are represented in the same color as the bubble colors along with the p-value and FDR q-value. (D) 
The overrepresented genes were queried against the Reactome pathway within GSEA and are depicted in the bubble chart. Five bubbles 
(starting from “Genes involved in Neuronal System” in the table) depict the pathways with highest p-values and FDR q-values altered 
upon overexpressed PSMD10Gankyrin. Each bubble represents a pathway with number genes as appeared in the GSEA gene set. The table 
represents the top 8 pathways with corresponding p-value and FDR q-value highlighting the neuronal pathways in the same color as the 
bubble color. (E) Table shows the list of top neuron specific genes which are significantly upregulated upon PSMD10Gankyrin overexpression 
in HEK293 cells as determined by microarray. Overexpression of PSMD10Gankyrin in stable clone as compared to the vector control cells 
is included as a reference. (F) Bar graphs shows validation of microarray data by real time PCR for Ngn1 and Nrg1 genes. PSMD10Gankyrin
levels in stable clone as measured by real time PCR is also shown. Data represents the average fold increase of mRNA levels (normalized 
with GAPDH) from three independent experiments. The bubble chats were prepared by online tool https://www.onlinecharttool.com.
and Supplementary Fig. S2). After 14 days of incubation 
in media without growth factors (EGF and FGF) the 
hNPCs differentiated largely to astrocytic cells (∼80 to 
90%), a small fraction to neurons (∼10 to 15%) (Fig. 2D), 
and the oligodendrocyte cells were sparingly populated 
(Supplementary Fig. S1A).
  We checked PSMD10Gankyrin levels in the undifferen-
tiated progenitor cells (UD) and after 14 days in the ter-
minally differentiated cells (DF). PSMD10Gankyrin protein 
levels (Fig. 2E, 2F) as well as mRNA levels (Fig. 2G, 2H) 
are significantly elevated in DF cells as compared to UD 
cells. In contrast, other proteasome subunits representing 
each of the sub-complex (α4 and β7 from 20S-CP; Rpt6, 
an ATPase and PSMD9, a non-ATPase subunit of 19S-RP) 
either showed a small decrease or remained unaltered in 
their protein and mRNA levels (Fig. 2E, 2F and 2I). 
Decreased expression of few proteasome subunits both in 
protein levels (α4, β7 and Rpt6) and mRNA levels (β1, 
β5, β7 and PSMD4) may indicate an altered proteasome 
levels and activity; however, further investigation in the 
future is needed to understand the significance of these 
observations.
  An important outcome of the topological network analy-
ses is that the independent identified nodes are well estab-
lished for their role in neurogenesis. Among them are 
Ngn1, a key transcriptional regulator of genes encoding key 
transcription factors of neurogenesis (16) and β-catenin 
which directly binds to Ngn1 promotor and regulates its 
expression during neuronal differentiation of NPC (17). 
Furthermore, β-catenin and PSMD10Gankyrin mutually reg-
ulate expression of each other (10). In support of this, in 
PSMD10Gankyrin overexpressing HEK293 cells, an increase in 
β-catenin protein levels (Fig. 3A), mRNA levels (Fig. 3B), 
and its transcriptional activity (Fig. 3C) were observed. 
Correspondingly, silencing PSMD10Gankyrin by siRNA reduced 
the mRNA levels (Fig. 3D) and transcriptional activity 
(Fig. 3E) of β-catenin. Since hNPCs after differentiation 
showed higher PSMD10Gankyrin levels, we tested β-catenin 
levels under undifferentiated (UD) and differentiated con-
ditions (DF). β-catenin protein levels showed a significant 
increase in the DF cells than in UD cells (Fig. 3F). We 
also checked the mRNA levels of Ngn1 and Nrg1; both were 
indeed upregulated in the differentiated populations as 
compared to undifferentiated hNPCs (Fig. 3G, 3H). Nrg1, 
one of the upregulated genes in the microarray data, be-
longs to family of proteins known to induce growth and dif-
ferentiation of epithelial, glial and neuronal cells (18, 19). 
Interestingly, Nrg1 was upregulated in PSMD10Gankyrin sta-
ble cells (Fig. 1F) and downregulated upon silencing 
PSMD10Gankyrin in HEK293 cells (Fig. 3D).
  To confirm the observed association between PSMD10Gankyrin 
levels and cell lineage commitment, we monitored PSMD-
10Gankyrin expression pattern during the differentiation 
process. hNPCs were differentiated for 10 days (Fig. 3I) 
and cell extracts prepared at different days (total of 8 time 
points) were analyzed by immunoblotting. Nestin levels 
steadily decreased indicating that hNPCs are now commit-
ted to the process of differentiation (20). The differ-
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Fig. 2. Differentiated human Neuronal progenitor cells (hNPCs) shows higher expression of PSMD10Gankyrin. (A) Progenitor cells were cultured 
on laminin coated glass coverslips to ∼80% confluence. Immunofluorescence was performed following the protocol described in materials 
and methods. Cells stained positive for Nestin (in red) Sox2 (in green), Musashi (in green) and DAPI (nuclear stain; in blue). Images were 
acquired in a Laser confocal microscope (Zeiss LSM meta-510). (B) Progenitor cells were grown as described and differentiated using differ-
entiation media. Media was changed every alternative day. Cultures were processed for further experiments on the 12th day of differentiation. 
Immunofluorescence was performed following the protocol described in materials and methods. Cells stained for β-III tubulin (in red), 
and GFAP (in green) indicating the formation of neurons and astrocytes respectively. (C) Cell lysates of hNPCs and differentiated cells 
were subjected to WB. Image shows the expression of stem cell and differentiation markers in the progenitor cells (UD) and differentiated 
cells (DF) respectively. (D) The bar graph represents the percentage of neurons and astrocytes differentiated from above experiments (Fig. 
2B). Data represents average of the percentage of cells from three independent experiments, each counted from 12 different fields (12×3=36
microscopic fields). (E) WB images of cell lysates of hNPCs and differentiated cells show expression of PSMD10Gankyrin and other proteasomal 
subunits in the progenitor cells (UD) and differentiated cells (DF). (F) The bar graph represents the quantification of proteasomal subunits 
protein level expression counted from above experiments (Fig. 2B) in fold change (from three independent experiments with±SEM) in 
DF cells compared to UD cells after normalizing with β-actin. (G) Semi-Q PCR gel image shows the mRNA levels of PSMD10Gankyrin
in the progenitor cells (UD) and differentiated cells (DF). (H) Graph represents mRNA levels of PSMD10Gankyrin in the progenitor cells (UD) 
and differentiated cells (DF) measured by the Real-time PCR. Data represents the average fold increase of mRNA levels (normalized with 
GAPDH) of three independent experiments with±SEM. (I) Semi-Q PCR gel image shows the mRNA levels of proteasomal subunits in the 
progenitor cells (UD) and differentiated cells (DF).
entiation marker GFAP unique to astrocytes detected on 
the very first day (Day1) of differentiation and continued 
to increase until the last day (Day10). The neuronal mark-
er β-III tubulin detected at Day-4, increased gradually 
until Day-10 of the differentiation process (Fig. 3J, 3K). 
Concurrently, the levels of PSMD10Gankyrin increased line-
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Fig. 3. PSMD10Gankyrin expression increases during the hNPCs differentiation process. (A) PSMD10Gankyrin Stable clone (P10 Over-Ex) in 
HEK293 cells were analyzed for PSMD10Gankyrin and β-catenin protein levels by western blot. (B) The graph shows the real-time PCR 
analyzed, significant increase in mRNA levels of β-catenin in the PSMD10Gankyrin overexpression clone with the error bar corresponding 
to the ±SEM of two independent experiments done in duplicates. GAPDH is used as loading control and for normalization. (C) 
PSMD10Gankyrin Stable clone and control HEK293 cells were transfected with TopFlash and renilla constructs at a ratio of 10：1 respectively 
and were lysed 48 hr post-transfection. Graph shows the average fold increase with ±SEM in β-catenin transcriptional activity normalized 
with renilla luciferase activity from two independent experiments done in duplicates. (D) HEK293 cells were transfected with PSMD10Gankyrin
siRNA/control siRNA and were grown for 48 hr then RNA was isolated. The three graphs show the real-time PCR analyzed significant 
decrease in mRNA levels of PSMD10Gankyrin, β-catenin and Nrg1 with the error bar corresponding to the ±SEM of duplicate experiments. 
GAPDH is used as loading control and for normalization. (E) HEK293 cells were transfected with PSMD10Gankyrin siRNA/control siRNA, 
incubated for 48 hr and then transfected with TopFlash and renilla construct at a ratio of 10：1 respectively and were lysed 24 hr 
post-transfection. Graph shows the average fold change with ±SEM in β-catenin transcriptional activity normalized with renilla luciferase 
activity from duplicate experiments. (F) Neuronal Progenitor cells grown on laminin coated plates to ∼80% confluence were differentiated 
as described in Fig. 2 with a minor change; differentiation was stopped at day 10. WB images of cell lysates of hNPCs and differentiated 
cells show expression of PSMD10Gankyrin and β-catenin in the progenitor cells (UD) and differentiated cells (DF). (G) Semi-Q PCR gel 
image shows the mRNA levels of PSMD10Gankyrin and Ngn1 in the above mentioned progenitor cells (UD) and differentiated cells (DF). 
(H) Graphs represents mRNA levels of Ngn1 and Nrg1 in the progenitor cells (UD) and differentiated cells (DF) measured by the Real-time 
PCR. Data represents the average fold increase of mRNA levels (normalized with GAPDH) of three independent experiments with ±SEM.
(I) Phase-contrast images show day wise differentiation status of the hNPCs. (J) Cells at each day of differentiation were collected, lysed 
and analyzed by western blot using antibodies mentioned in the figure. (K) Line graphs show the expression levels of various proteins 
from Fig. 3J at each day during the differentiation process. Data represents the average protein levels of two independent (biological repeat) 
experiments.
arly until the end of the differentiation process and paral-
leled the increase in β-III tubulin during the late stage 
of differentiation. The quantum increase in PSMD10Gankyrin co-
incident with the quantum increase in βIII-tubulin sug-
gested a profound role for PSMD10Gankyrin in the differ-
entiation of hNPCs to neurons. In addition, the expression 
of STAT3 and phosphorylation of STAT3 correlate with 
the expression of PSMD10Gankyrin during the differ-
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Fig. 3. Continued.
entiation process until day 6 (Supplementary Fig. S3A, 
S3B). However, in the terminally differentiated cells the 
phosphoSTAT3 levels and mRNA levels of STAT3 (Sup-
plementary Fig. S3C, S3D) went down indicating suppres-
sion of STAT3 activity. These results together suggest a 
probable involvement of PSMD10Gankyrin in glial cell line-
age during the initial days of differentiation.
PSMD10Gankyrin overexpression enhances neurogenesis 
in hNPCs 
  In order to test the aforementioned relationships, we 
overexpressed doxycycline inducible Flag-PSMD10Gankyrin 
in hNPCs by viral transduction and checked the induction 
of β-catenin and Ngn1 and the consequence on cell 
lineage. Upon Dox-induced PSMD10Gankyrin overexpression 
in hNPCs and after 12 days differentiation, the neuron 
count in total differentiated population increased from 
10% to ∼25% indicating a 2 to 2.5-fold increase in neuro-
nal population (Fig. 4A, 4B). Western blot of the 
Dox-treated and untreated DF cell lysates showed sig-
nificant increase in βIII-tubulin (Fig. 4C). Strikingly, 
both β-catenin and Ngn1 levels increased 2 to 3 fold in 
the differentiated population when PSMD10Gankyrin was 
overexpressed (Fig. 4D∼F). Furthermore, when 
PSMD10Gankyrin overexpressing (Dox treated) hNPCs were 
treated with neurotropin-3 (NT3) they showed higher lev-
els of βIII-tubulin expression than that of the Dox-un-
treated cells while levels of GFAP remained unaltered 
(Fig. 4G, 4H). These results are strongly suggestive of the 
possible functional association between PSMD10Gankyrin 
and Ngn1 quite likely via β-catenin. PSMD10Gankyrin may 
be a key player in the network of proteins responsible for 
neurogenesis. 
  To establish the causal effect of PSMD10Gankyrin in neu-
rogenesis, the hNPCs expressing Flag-PSMD10Gankyrin were 
analyzed for the composition of the cell types (Fig. 4I). 
After 12 days of differentiation, immunofluorescence stud-
ies indicated that ∼60% of Flag-PSMD10Gankyrin express-
ing cells differentiated into neurons and ∼40% 
Flag-PSMD10Gankyrin expressing cells differentiated into as-
trocytes (Fig. 4J, 4K). This shift in the ratio of neurons：
astrocytes (i.e. from 1：9 to 3：2) in the untreated cells 
versus transduced-Dox treated cell population, parallels 
the overall increase seen in neuron counts upon doxycy-
cline treatment (from 10% to ∼25% in Fig. 4A). 
Significant, but small increase in the overall neuron count 
may be due to the low transduction efficiency (∼20 to 30%, 
Supplementary Fig. S4). The presence of astrocyte marker 
in cells that express Flag-PSMD10Gankyrin indicates that 
PSMD10Gankyrin driven shift in neurogenesis is not absolute 
which could be due to the following reasons: (1) The cur-
rent differentiation protocol supports astrocyte formation 
more than neurons. Therefore, PSMD10Gankyrin overexpression 
induced signaling events or transcriptional programing 
may not be enough to execute an exclusive switch to 
neurogenesis. (2) PSMD10Gankyrin overexpression may trig-
ger “lateral inhibition phenomena” responsible for regu-
lated differentiation of different cell types in a mixed 
population. (3) PSMD10Gankyrin may favor the formation of 
both neurons and astrocytes in a spatio-temporal manner. 
Although less strong than that of βIII-tubulin, correlation 
between phosphoSTAT3 levels and PSMD10Gankyrin during 
the early days of differentiation (Supplementary Fig. S3) 
is suggestive of such a dual role.
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Fig. 4. PSMD10Gankyrin overexpression in hNPCs facilitate neuronal differentiation process. hNPCs were grown on laminin coated glass cover-
slips till they reached ∼30% confluency. Then cells were transduced with virus particles carrying pTRIPZ-3XFlag- PSMD10Gankyrin and cells 
were either treated with doxycycline (1 μg/mL) for 48 hr or left untreated. Once ∼80% confluency was reached, media was replaced 
with fresh differentiation media. Subsequently, differentiation media was replaced every alternate day and contained doxycycline (1 μg/mL) 
or no doxycycline until the 12th day of differentiation. (A) Cells were immunostained using β-III tubulin antibody (in red) following the 
protocol described in materials and methods. DAPI (in blue) was used for nuclear staining. (B) The bar graph represents the fold increase 
in the number of neurons differentiated from hNPCs with/without overexpression of Flag-P10 in the total pool of hNPCs. Data represents 
average number of cells from two independent experiments (in fold increase) each from 10 different fields (10×2=20 microscopic fields). 
(C) WB image of the above cells shows levels of β-III tubulin and β-catenin. (D) The bar graph shows the average fold increase with 
±SEM in β-catenin protein levels in differentiated hNPCs (DF) treated with/without Doxycycline. β-actin was used as loading control 
and for normalization. (E) Semi-Q PCR gel image shows the mRNA levels of PSMD10Gankyrin and Ngn1 in the progenitor cells (Dox-ve 
UD) and differentiated cells (Dox-ve DF & Dox＋ve DF). (F) The realtime-PCR bar graph represents the mRNA levels of Ngn1 in the 
differentiated cells (cont-DF & Flag-P10 DF). Data represents the average fold increase of mRNA levels (normalized with GAPDH) of three 
independent experiments. (G) hNPCs cells were either treated with Doxycycline and/or 10 ng/mL NT3 or left untreated during the differ-
entiation process (for 10 days) and cell lysates were prepared for WB. Image shows levels of β-III tubulin, β-catenin and FLAG- PSMD10. 
(H) The bar graph shows the protein level quantification of GFAP and β-III tubulin with average value ±SEM from three different experi-
ments with experimental set-up explained in Panel-I. β-actin was used as loading control and for normalization. (I) Model figure represents 
the workflow for tracing hNPCs fate after PSMD10Gankyrin overexpression. (J) Immunofluorescence was performed in above cells treated 
with/without Doxycycline; following the protocol described in materials and methods. In Dox＋ve staining, cells (white arrow marked) 
expressing Flag-PSMD10Gankyrin (green) also stain for β-III tubulin (red). They are GFAP negative (purple). Cells (red arrow marked) expressing 
Flag-PSMD10Gankyrin (green) also stain for GFAP (purple). (K) Bar graph represents the percentage of neurons and astrocytes differentiated 
from hNPCs without and with (Dox treatment) overexpression of Flag-PSMD10Gankyrin. For Dox＋ve set those cells which expressed 
Flag-PSMD10Gankyrin were only considered for neuron and astrocyte count. Data represents the average number of cells (in percentage) 
from three independent experiments, with data collected from 10 fields in each case (10×3=30 microscopic fields). (L) Model figure based 
on previously reported role of Ngn1 and results from the current study shows the probable role of PSMD10Gankyrin in hNPCs differentiation 
via β-catenin Ngn1 pathway.
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Fig. 4. Continued.
  The results presented here demonstrate a definite corre-
lation between the levels of PSMD10Gankyrin and the key 
players such as β-catenin and Ngn1. Microarray analysis 
of differentially expressed genes induced by PSMD9, a 
regulator of NF-κB activation (21) did not confer an 
overwhelming signature for neurogenesis by any of the 
computational analysis described above (data not shown). 
In agreement there was no change in the expression of this 
gene in the course of differentiation of the NPC cells (Fig. 
3J). Thus, the gene signature and experimental evidence 
obtained in the present study is associated specifically 
with PSMD10Gankyrin. Strengthened by integrated network 
approach involving topological analysis, gene enrichment 
and pathway analysis of a microarray data coupled with 
experimental validation, PSMD10Gankyrin emerges as a new 
player in cell fate decisions. Here we provide preliminary 
but compelling evidence for the role of PSMD10Gankyrin in 
neurogenesis of human neuronal progenitor cells possibly 
by stabilizing the β-Catenin and subsequent increase in 
Ngn1 expression and activity (Fig. 4L).
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